IR Contact

Investor Relations And Corporate Communications

Temre Johnson

Director, Investor Relations and Corporate Communications
Mirati Therapeutics
858-332-3562
ir@mirati.com

Name *
 
Email *
 
Subject *
 
Comments *
 
 
Enter the code shown above.